John L. Marshall M.D., explains the importance of in-person conferences and the future of AI in the field.
ESMO World Congress on GI Cancer 2023
The LEAP-017 trial results presented at ESMO GI 2023 are explored by Dr Marshall.
Dr Marshall discusses challenges associated with microsatellite stable metastatic colorectal cancer.
An overview of data presented at ESMO GI 2023 on combined botensilimab and balstilimab therapy in heavily pretreated patients with microsatellite stable metastatic colorectal cancer.
Dr Marshall describes the impacts of microsatellite stability and instability on metastatic colorectal cancer.
Discussion on shared decision making with patients with later stage refractory metastatic colorectal cancer as well as maximizing a patient's quality of life.
John L. Marshall M.D., shares insights on health-related quality of life (HRQoL) findings from SUNLIGHT study presented at ESMO World Congress on Gastrointestinal Cancer (ESMO GI) 2023.
Advertisement
Advertisement
Trending on AJMC
1
Government Shutdown Could Disrupt Health Care Access
2
Most Medicare Beneficiaries Find Plan Shopping Confusing, Survey Finds
3
Maternal, Child Mortality Higher in the US Compared With Majority of High-Income Countries
4
Lurbinectedin Combo Approved by FDA for Extensive-Stage Small Cell Lung Cancer
5
